Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Ascorbic acid alleviates toxicity of paclitaxel without interfering with the anticancer efficacy in mice.

Park JH, Davis KR, Lee G, Jung M, Jung Y, Park J, Yi SY, Lee MA, Lee S, Yeom CH, Kim J.

Nutr Res. 2012 Nov;32(11):873-83. doi: 10.1016/j.nutres.2012.09.011. Epub 2012 Oct 26.

PMID:
23176798
2.

Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.

Alexandre J, Nicco C, Chéreau C, Laurent A, Weill B, Goldwasser F, Batteux F.

J Natl Cancer Inst. 2006 Feb 15;98(4):236-44.

PMID:
16478742
3.

In vivo assessment of toxicity and pharmacokinetics of methylglyoxal. Augmentation of the curative effect of methylglyoxal on cancer-bearing mice by ascorbic acid and creatine.

Ghosh M, Talukdar D, Ghosh S, Bhattacharyya N, Ray M, Ray S.

Toxicol Appl Pharmacol. 2006 Apr 1;212(1):45-58. Epub 2005 Aug 19.

PMID:
16112157
4.

2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.

Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, De Young LR, Lampidis TJ.

Cancer Res. 2004 Jan 1;64(1):31-4.

5.

Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.

Shalinsky DR, Brekken J, Zou H, Bloom LA, McDermott CD, Zook S, Varki NM, Appelt K.

Clin Cancer Res. 1999 Jul;5(7):1905-17.

6.

Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non small cell lung cancer.

Pathak AK, Bhutani M, Guleria R, Bal S, Mohan A, Mohanti BK, Sharma A, Pathak R, Bhardwaj NK, Prasad KN, Kochupillai V.

J Am Coll Nutr. 2005 Feb;24(1):16-21.

PMID:
15670980
7.

[Tumor growth inhibition of paclitaxel-octreotide conjugates on human non small cell lung cancer: experiment with mice].

Shen HC, Wang XW, Liu YG.

Zhonghua Yi Xue Za Zhi. 2008 Sep 16;88(35):2498-503. Chinese.

PMID:
19080633
8.

Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

Hainsworth JD, Burris HA 3rd, Morrissey LH, Thomas M, Erland JB, Butts JA, Joseph G, Kalman L, Greco FA.

Cancer J. 2000 May-Jun;6(3):151-6.

PMID:
10882330
9.

Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.

Sreekanth CN, Bava SV, Sreekumar E, Anto RJ.

Oncogene. 2011 Jul 14;30(28):3139-52. doi: 10.1038/onc.2011.23. Epub 2011 Feb 14.

PMID:
21317920
10.

High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis.

Yeom CH, Lee G, Park JH, Yu J, Park S, Yi SY, Lee HR, Hong YS, Yang J, Lee S.

J Transl Med. 2009 Aug 11;7:70. doi: 10.1186/1479-5876-7-70.

11.
13.

In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.

Fahham D, Weiss ID, Abraham M, Beider K, Hanna W, Shlomai Z, Eizenberg O, Zamir G, Izhar U, Shapira OM, Peled A, Wald O.

J Thorac Cardiovasc Surg. 2012 Nov;144(5):1167-1175.e1. doi: 10.1016/j.jtcvs.2012.07.031. Epub 2012 Aug 24.

14.
15.

Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.

Patil Y, Sadhukha T, Ma L, Panyam J.

J Control Release. 2009 May 21;136(1):21-9. doi: 10.1016/j.jconrel.2009.01.021. Epub 2009 Feb 5.

PMID:
19331851
16.

Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.

Latimer P, Menchaca M, Snyder RM, Yu W, Gilbert BE, Sanders BG, Kline K.

Exp Biol Med (Maywood). 2009 Oct;234(10):1244-52. doi: 10.3181/0901-RM-8. Epub 2009 Aug 5.

PMID:
19657067
17.

Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells.

Knick VC, Eberwein DJ, Miller CG.

J Natl Cancer Inst. 1995 Jul 19;87(14):1072-7.

PMID:
7616599
18.
19.

Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.

Sakurai Y, Yoshida I, Kamoshida S, Inaba K, Isogaki J, Komori Y, Uyama I, Tsutsumi Y.

Ann Surg Oncol. 2008 Aug;15(8):2301-9. doi: 10.1245/s10434-008-9963-5. Epub 2008 May 28.

PMID:
18506536
20.

Enhancement of antitumor effects of paclitaxel (taxol) in combination with red ginseng acidic polysaccharide (RGAP).

Shin HJ, Kim YS, Kwak YS, Song YB, Kim YS, Park JD.

Planta Med. 2004 Nov;70(11):1033-8.

PMID:
15549658

Supplemental Content

Support Center